Labsystems Diagnostics Oy of Vantaa at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Labsystems Diagnostics Oy

Tiilitie 3, 01720 Vantaa
Telephone +358 20 1557530
Fax +358 20 1557521

This company is co-exhibitor of
Wulff Entre Ltd.

Hall map

MEDICA 2018 hall map (Hall 7): stand D37

Fairground map

MEDICA 2018 fairground map: Hall 7

Our range of products

Product categories

  • 02  Laboratory Technology
  • 02.09  Laboratory equipment

Laboratory equipment

Our products

Product category: Laboratory equipment

Enzymatic Immuno Assays (EIA)

In the current scenario, fully automated instruments in medical laboratories across the world use the immunoassay principle with an enzyme as the reporter label for routine measurements of innumerable analytes in patient samples. Designed to be very sensitive, this Enzyme Immunoassay (EIA) is used to detect the presence of a substance, usually an antigen, in a liquid sample or wet sample.

More Less

About us

Company details

Accurate diagnostic tests play a key role in patient management and the control of most dangerous diseases. A major outreach effort made by combining scientific, technological and academic expertise is needed for developing next-generation diagnostic tests.

With a similar vision, Labsystems Diagnostics Oy, a Finnish establishment develops, manufactures, markets and sells high-quality diagnostic tests globally for clinical laboratory use, home use and doctors’ offices. After the acquisition by the India-based global healthcare group Trivitron, Labsystems Diagnostics Oy raised the bars in the In Vitro Diagnostics sector.

Featured Products
  • The predominant innovation from the house of Labsystems Diagnostics Oy is their complete range of Newborn Screening systems and tests. From fully integrated robotic platforms to systems based on fluorescence detection and various assays for diagnosis, Labsystems stands as the second most important manufacturer of newborn screening tests worldwide.
  • Labsystems Diagnostics is a house of repute for the infectious disease tests for more than three decades. They are the first diagnostics manufacturing facility to create EIA tests on a microplate format and EIA tests based on peptide technology. Currently, they produce well recognized high-quality EIA tests,convenient duplex real-time PCR tests and Biocard POC tests especially for respiratory infections.
  • Labsystems developed their own brand called BiocardTM, which is a trademark listed in the Master lists of the College of American Pathologists (CAP) Proficiency testing (PT). Under their BiocardTM Point-of-Care brand, they developed the first and only tests available for detecting Chlamydia pneumoniae and Mycoplasma pneumoniae. Along with this, they also manufacture Gastro and Cardiac POC tests under the same BiocardTM brand.
  • Labsystems Diagnostics marked its name as an experienced OEM producer for several home tests products such as Pregnancy tests, Ovulation tests and the patented Celiac tests.
Labsystems Diagnostics Oy design, development, manufacturing, marketing and sales of reagents and reagent products are in line with several regulations. Equipped with automated robotics assembly and production lines, Labsystems delivers quality in accordance with ISO 13485 and IVDD CE guidelines.

More Less